The current and future view of antidepressant development from pharmaceutical industry perspectives

Japanese Journal of Neuropsychopharmacology

Volumn 31, Issue 4, 2011, Pages 181-186

  Arano, Ichiro ^a   Imaeda, Takayuki ^a  

^a PFIZER INC   (United States)

Author keywords

Antidepressant; Depression; Global clinical study; Placebo controlled study

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

CLINICAL PRACTICE; DEPRESSION; DRUG INDUSTRY; DRUG RESEARCH; HUMAN; JAPAN; REVIEW; RISK ASSESSMENT; CLINICAL TRIAL (TOPIC); DRUG DEVELOPMENT; FORECASTING; INTERNATIONAL COOPERATION; METHODOLOGY;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEPRESSION; DRUG DISCOVERY; DRUG INDUSTRY; FORECASTING; HUMANS; INTERNATIONAL COOPERATION; PLACEBOS;

EID: 80053536528     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Bridge, J. A., Birmaher, B., Iyengar, S., Barbe, R. P. and Brent, D. A. (2009) Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry, 166: 42-49.
2. Faries, D. E., Heiligenstein, J. H., Tollefson, G. D. and Potter, W. Z. (2001) The double-blind variable placebo lead-in period: Results from two antidepressant clinical trials. J Clin Psychopharmacol, 21: 561-568. (Pubitemid 33116654)
3. Fava, M., Evins, A. E., Dorer, D. J. and Schoenfeld, D.A. (2003) The problem of the placebo response in clinical trials for psychiatric disorders: Culprits, possible remedies, and a novel study design approach. Psychother Psychosom, 72: 115-127. (Pubitemid 36469860)
4. Fluvoxamine. http://clinicaltrials.gov/ct2/show/NCT00353028?term= fluvoxamine+Japan&rank=2
5. http://www.mhlw.go.jp/stf/shingi/2r9852000000w1az-att/2r9852000000w1hq. pdf
6. Khan, A., Bhat, A., Kolts, R., Thase, M. E. and Brown, W. (2010) Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades? CNS Neurosci Ther, 16: 217-226.
7. Kobak, K. A., Feiger, A. D. and Lipsitz, J. D. (2005) Interview quality and signal detection in clinical trials. Am J Psychiatry, 162: 628. (Pubitemid 40343943)
8. Kobak, K. A., Kane, J.M, Thase, M.E. and Nierenberg, A. A. (2007) Why do clinical trials fail? The problem of measurement error in clinical trials: Time to test new paradigms? J Clin Psychopharmacol, 27: 1-5. (Pubitemid 46105756)
9. Kobak, K. A., Leuchter, A., DeBrota, D., Engelhardt, N., Williams, J. B., Cook, I. A., Leon, A. C. and Alpert, J. (2010) Site versus centralized raters in a clinical depression trial: Impact on patient selection and placebo response. J Clin Psychopharmacol, 30: 193-197.
10. Laughren, T. P. (2001) The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: An FDA perspective. Eur Psychiatry, 16: 418-423.
11. Liu, K. S., Snavely, D. B., Ball, W. A., Lines, C. R, Reines, S. A. and Potter, W. Z. (2008) Is bigger better for depression trials? J Psychiatr Res, 42: 622-630. (Pubitemid 351626061)
12. LY2140023. http://www.clinicaltrials.gov/ct2/show/NCT01086748?term= LY2140023&rank=5
13. Medavante http://www.medavante.net/Products/RemoteCentralizedRatings.aspx
14. Papakostas, G. I. and Fava, M. (2009) Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol, 19: 34-40.
15. Paroxetine. http://clinicaltrials.gov/ct2/show/NCT00812812?term= paroxetine+Japan&rank=3
16. Perlis, R. H., Ostacher, M., Fava, M., Nierenberg, A. A., Sachs, G. S. and Rosenbaum, J. F. (2010) Assuring that double-blind is blind. Am J Psychiatry, 167: 250-252.
17. Rief, W., Nestoriuc, Y., Weiss, S., Welzel, E., Barsky, A. J. and Hofmann, S. G. (2009) Meta-analysis of the placebo response in antidepressant trials. J Affect Disord, 118: 1-8.
18. Rutherford, B. R., Sneed, J. R. and Roose, S. P. (2009) Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom, 78: 172-181.
19. Shelton, R. C., Prakash, A., Mallinckrodt, C. H., Wohlreich, M. M., Raskin, J., Robinson, M. J. and Detke, M. J. (2007) Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression. Int J Clin Pract, 61: 1337-1348. (Pubitemid 47052368)
20. Walsh, B. T., Seidman, S. N., Sysko, R. and Gould, M. (2002) Placebo response in studies of major depression: Variable, substantial, and growing. JAMA, 287: 1840-1847. (Pubitemid 34303629)